Abstract
The standard medical education in Western medicine has emphasized skills and knowledge learned from experts, particularly those encountered in the course of postgraduate medical education, and through national publications and meetings. This reliance on experts, referred to by Dr. Paul Gerber of Dartmouth Medical School as “eminence-based medicine” (1), is based on the construct that the individual practitioner, particularly a specialist devoting extensive time to a given discipline, can arrive at the best approach to a problem through his or her experience. The practitioner builds up an experience base over years and digests information from national experts who have a greater base of experience due to their focus in a particular area. The evidence-based imaging (EBI) paradigm, in contradistinction, is based on the precept that a single practitioner cannot through experience alone arrive at an unbiased assessment of the best course of action. Assessment of appropriate medical care should instead be derived through evidence-based process. The role of the practitioner, then, is not simply to accept information from an expert, but rather to assimilate and critically assess the research evidence that exists in the literature to guide a clinical decision (2–4).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Levin A. Ann Intern Med 1998;128:334–336.
Evidence-Based Medicine Working Group. JAMA 1992;268:2420–2425.
The Evidence-Based Radiology Working Group. Radiology 2001;220:566–575.
Wood BP. Radiology 1999;213:635–637.
Poisal JA et al. Health Aff 2007;26:w242–w253.
Davis K. N Engl J Med 2008;359:1751–1755.
Hulley SB, Cummings SR. Designing Clinical Research. Baltimore: Williams & Wilkins, 1998.
Kelsey J, Whittemore A, Evans A, Thompson W. Methods in Observational Epidemiology. New York: Oxford University Press, 1996.
Blackmore C, Cummings P. AJR Am J Roentgenol 2004;183(5):1203–1208.
Medina L, Aguirre E, Zurakowski D. Neuroimaging Clin N Am 2003;13:157–165.
Medina L. AJNR Am J Neuroradiol 1999;20:1584–1596.
Sunshine JH, McNeil BJ. Radiology 1997;205:549–557.
Black WC. AJR Am J Roentgenol 1990;154:17–22.
Sox HC, Blatt MA, Higgins MC, Marton KI. Medical Decision Making. Boston: Butterworth, 1988.
Metz CE. Semin Nucl Med 1978;8:283–298.
Singer M, Applegate K. Radiology 2001;219: 611–620.
Weinstein MC, Fineberg HV. Clinical Decision Analysis. Philadelphia: WB Saunders, 1980.
Carlos R. Acad Radiol 2004;11:141–148.
Detsky AS, Naglie IG. Ann Intern Med 1990;113:147–154.
Doubilet P, Weinstein MC, McNeil BJ. N Engl J Med 1986;314:253–256.
Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
Hillemann D, Lucas B, Mohiuddin S, Holmberg M. Ann Pharmacother 1997;31:974–979.
Medina L, Aguirre E, Bernal B, Altman N. Radiology 2004;230:49–54.
Appel LJ, Steinberg EP, Powe NR, Anderson GF, Dwyer SA, Faden RR. Med Care 1990;28:324–337.
Evens RG. Cancer 1991;67:1245–1252.
Yin D, Forman HP, Langlotz CP. AJR Am J Roentgenol 1995;165:1323–1328.
Medina L, Crone K, Kuntz K. Pediatrics 2001;108:E101.
Ware JE, Sherbourne CD. Med Care 1992;30:473–483.
Jarvik J, Hollingworth W, Martin B, et al. JAMA 2003;2810–2818.
Blackmore CC, Magid DJ. Radiology 1997;203: 87–91.
Medina L, Aguirre E, Altman N. Acad Radiol 2003;10:139–144.
Zou K, Fielding J, Ondategui-Parra S. Acad Radiol 2004;11:127–133.
Langlotz C, Sonnad S. Acad Radiol 1998;5(suppl 2):S269–S273.
Littenberg B, Moses LE. Med Decis Making 1993;13:313–321.
Terasawa T, Blackmore C, Bent S, Kohlwes R. Ann Intern Med 2004;141(7):37–546.
Fryback DG, Thornbury JR. Med Decis Making 1991;11:88–94.
Blackmore C. Radiology 2005;235(2):371–374.
Jaeschke R, Guyatt GH, Sackett DL. JAMA 1994;271:703–707.
Malone D. Radiology 2007;242(1):12–14.
Medina LS, Blackmore DD. Evidence-Based Imaging: Optimizing Imaging in Patient. New York: Springer Science+Business Media, 2006.
Acknowledgment:
We appreciate the contribution of Ruth Carlos, MD, MS, to the discussion of likelihood ratios in this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendices
IV. Take Home Appendix 1: Equations
Test result | Present | Outcome | Absent |
Positive Negative | a (TP) c (FN) | b (FP) d (TN) | |
a.Sensitivity | a/(a + c) | ||
b.Specificity | d/(b + d) | ||
c.Prevalence | (a + c)/(a + b + c + d) | ||
d.Accuracy | (a + d)/(a + b + c + d) | ||
e.Positive predictive valuea | a/(a + b) | ||
f.Negative predictive valuea | d/(c + d) | ||
g.95% confidence interval (CI) | \( {\rm p} \pm \sqrt{\frac{\rm p(1-n)}{\rm n}}\) p = proportion n = number of subjects | ||
h.Likelihood ratio | \(\frac{\rm Sensitivity}{1-\rm specificity}=\frac{\rm a(b+d)}{\rm b(a+c)}\) |
V. Take Home Appendix 2: Summary of Bayes’ Theorem
-
A.
Information before test × Information from test = Information after test
-
B.
Pretest probability (prevalence) sensitivity/ 1 − specificity = posttest probability (predictive value)
-
C.
Information from the test also known as the likelihood ratio, described by the equation: sensitivity/1 − specificity
-
D.
Examples 1 and 2 predictive values: The predictive values (posttest probability) change according to the differences in prevalence (pretest probability), although the diagnostic performance of the test (i.e., sensitivity and specificity) is unchanged. The following examples illustrate how the prevalence (pretest probability) can affect the predictive values (posttest probability) having the same information in two different study groups
Equations for calculating the results in the previous examples are listed in Appendix 1. As the prevalence of carotid artery disease increases from 0.16 (low) to 0.82 (high), the positive predictive value (PPV) of a positive contrast-enhanced CT increases from 0.67 to 0.98, respectively. The sensitivity and specificity remain unchanged at 0.83 and 0.92, respectively. These examples also illustrate that the diagnostic performance of the test (i.e., sensitivity and specificity) does not depend on the prevalence (pretest probability) of the disease. CTA, CT angiogram.
Example 1: Low prevalence of carotid artery disease | |||
---|---|---|---|
Disease (carotid artery disease) | No disease (no carotid artery disease) | Total | |
Test positive (positive CTA) | 20 | 10 | 30 |
Test negative (negative CTA) | 4 | 120 | 124 |
Total | 24 | 130 | 154 |
Example 2: High prevalence of carotid artery disease | |||
---|---|---|---|
Disease (carotid artery disease) | No disease (no carotid artery disease) | Total | |
Test positive (positive CTA) | 500 | 10 | 510 |
Test negative (negative CTA) | 100 | 120 | 220 |
Total | 600 | 130 | 730 |
Rights and permissions
Copyright information
© 2011 Springer New York
About this chapter
Cite this chapter
Medina, L.S., Blackmore, C.C., Applegate, K.E. (2011). 1 Principles of Evidence-Based Imaging. In: Medina, L., Blackmore, C., Applegate, K. (eds) Evidence-Based Imaging. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7777-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7777-9_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-7776-2
Online ISBN: 978-1-4419-7777-9
eBook Packages: MedicineMedicine (R0)